T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes

被引：13

作者：

Park, Hye Sun ^{[1
,2
]}

McIntosh, Lacey ^{[3
,4
]}

Braschi-Amirfarzan, Marta ^{[3
,4
]}

Shinagare, Atul B. ^{[3
,4
]}

Krajewski, Katherine M. ^{[3
,4
]}

机构：

[1] Univ Ulsan, Coll Med, Dept Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA

来源：

KOREAN JOURNAL OF RADIOLOGY | 2017年 / 18卷 / 01期

关键词：

T-cell lymphoma; Non-Hodgkin lymphoma; CT; MRI; PET-CT; NATURAL KILLER/T-CELL; LYMPHOBLASTIC LYMPHOMA; MYCOSIS-FUNGOIDES; PROGNOSTIC-FACTORS; UNITED-STATES; F-18-FDG PET/CT; SEZARY-SYNDROME; TRANSFORMATION; FEATURES; TRANSPLANTATION;

D O I：

10.3348/kjr.2017.18.1.71

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

T-cell non-Hodgkin Lymphomas (NHLs) are biologically diverse, uncommon malignancies characterized by a spectrum of imaging findings according to subtype. The purpose of this review is to describe the common subtypes of T-cell NHL, highlight important differences between cutaneous, various peripheral and precursor subtypes, and summarize imaging features and the role of imaging in the management of this diverse set of diseases.

引用

页码：71 / 83

页数：13

共 50 条

[41] The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas
Wasik, Agata M.
Christensson, Birger
Sander, Birgitta
SEMINARS IN CANCER BIOLOGY, 2011, 21 (05) : 313 - 321
[42] T-cell non-Hodgkin's lymphoma in adults: Clinicopathological characteristics, response to treatment and prognostic factors
Reiser, M
Josting, A
Soltani, M
Staib, P
Salzberger, B
Diehl, V
Engert, A
LEUKEMIA & LYMPHOMA, 2002, 43 (04) : 805 - 811
[43] Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms
Jiang, Manli
Bennani, N. Nora
Feldman, Andrew L.
EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (03) : 239 - 249
[44] Lymphoma classification update: B-cell non-Hodgkin lymphomas
Jiang, Manli
Bennani, N. Nora
Feldman, Andrew L.
EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (05) : 405 - 415
[45] The value of blood immunophenotyping and clonality testing in the management of cutaneous T-cell lymphomas
Bouthemy, C.
Beldi-Ferchiou, A.
Ortonne, N.
Delfau-Larue, M. -H.
Ingen-Housz-Oro, S.
Molinier-Frenkel, V.
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2017, 144 (04): : 315 - 322
[46] Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease
Argnani, Lisa
Broccoli, Alessandro
Zinzani, Pier Luigi
CANCER TREATMENT REVIEWS, 2017, 61 : 61 - 69
[47] Management of cutaneous T-cell lymphomas: Established and emergent therapies
Wain, Thevaki
Venning, Victoria L.
Consuegra, Germana
Fernandez-Penas, Pablo
Wells, Jillian
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 (03) : 200 - 208
[48] High proportion of T-cell systemic non-hodgkin lymphoma in HIV-Infected patients in Lima, Peru
Collins, JA
Hernández, AV
Hidalgo, JA
Villena, J
Sumire, J
Delgado, V
Salazar, R
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (05) : 558 - 564
[49] Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma
Ghobadi, Armin
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2018, 66 (02) : 43 - 49
[50] Different patterns of mast cell distribution in B-cell non-Hodgkin lymphomas
Guidolin, Diego
Tamma, Roberto
Annese, Tiziana
Tortorella, Cinzia
Ingravallo, Giuseppe
Gaudio, Francesco
Musto, Pellegrino
Specchia, Giorgina
Ribatti, Domenico
PATHOLOGY RESEARCH AND PRACTICE, 2023, 248

← 1 2 3 4 5 →